Sulaiman Alrajhi University signed a memorandum of understanding with Enigma Genetic Medicine to strengthen cooperation in research and specialised training in genetic medicine and the early detection of chronic and cancerous diseases, contributing to the development of advanced health solutions that improve quality of life.
The memorandum was signed by the University President, Dr. Muhammad A. Al-Mohaimeed, and the Chief Executive Officer of Enigma, Eng. Musaed Al-Dubayan.
The memorandum aims to support applied research in genetic medicine and the early detection of cancer, to develop specialised educational and training programmes, and to enable students and researchers to take up field and research training opportunities, in addition to exchanging expertise and scientific information to ensure the sustainability of the cooperation.
The signing of this memorandum reflects the importance of integration between academic institutions and research companies specialised in genetic medicine, and its role in developing innovative health solutions in the fields of early disease detection.
